Gain Therapeutics Inc (GANX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $46.31M
Last updated: Nov 17, 2026 at 4:42 PM ET
Gain Therapeutics Inc (GANX) Stock Chart
Gain Therapeutics (GANX) has a latest price of $1.18 on Nov 17, 2026, 72.8% below its 52-week high of $4.34. Its price fell 58.3% over the past 12 months. The month-end price fell 83.8% over the 5 years through Oct 2026, a compound annual decline of 30.5%.
Price Chart
From Mar 2021 to Oct 2026, its highest month-end close was $14.92 in Mar 2021 and its lowest $1.08 in Jul 2024, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart GANX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for GANX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 43.0%, and over 6 months it fell 25.8%. The month-end price fell 60.5% over the 3 years through Oct 2026, a compound annual decline of 26.6%.
| Period | Change |
|---|---|
| 1 month | -5.6% |
| 3 months | -43.0% |
| 6 months | -25.8% |
| 12 months | -58.3% |
| 12 months, with dividends | -58.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -60.5% | -26.6% |
| 5 years | -83.8% | -30.5% |
Price by Year
Its best calendar year was 2025, when the price rose 49.1%, and its weakest was 2022, when it fell 42.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.13 | -64.9% |
| 2025 | $3.22 | +49.1% |
| 2024 | $2.16 | -33.8% |
| 2023 | $3.27 | +4.3% |
| 2022 | $3.13 | -42.4% |
Trading Range
The price is 17.9% below its 50-day average of $1.44 and 34.7% below its 200-day average of $1.81.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.18 | |
| 52-week high | $4.34 | -72.8% |
| 52-week low | $0.94 | +25.5% |
| 50-day average | $1.44 | -17.9% |
| 200-day average | $1.81 | -34.7% |
Price Risk
Over 3 years, its largest fall from a peak was 81.4%.
| Measure | Value |
|---|---|
| 1-year beta | 1.64 |
| Largest fall, 1 year | -77.5% |
| Largest fall, 3 years | -81.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About GANX
What is GANX's 1-year price change?
Gain Therapeutics's price fell 58.3% over the past 12 months. With dividends included, the 12-month total return was -58.3%.
What is GANX's 5-year price change?
Gain Therapeutics's month-end price fell 83.8% over the 5 years through Oct 2026, a compound annual decline of 30.5%. These figures leave out dividends.
What is GANX's 52-week high and low?
Gain Therapeutics's 52-week high is $4.34 and its 52-week low is $0.94. Its latest price of $1.18 on Nov 17, 2026 is 72.8% below the high.
What is GANX's beta?
Gain Therapeutics's 1-year beta against the S&P 500 is 1.64, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 77.5%.
Is the GANX chart free?
Yes. Advanced Charting for GANX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
GANX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors